Ablation of Ezh2 in neural crest cells leads to aberrant enteric nervous system development in mice by Kim, Hana et al.
RESEARCH ARTICLE
Ablation of Ezh2 in neural crest cells leads to
aberrant enteric nervous system
development in mice
Hana Kim1, Ingeborg M. Langohr2, Mohammad Faisal1, Margaret McNulty2, Caitlin Thorn1,
Joomyeong Kim1*
1 Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana, United States of
America, 2 School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana, United States
of America
* jkim@lsu.edu
Abstract
In the current study, we examined the role of Ezh2 as an epigenetic modifier for the enteric
neural crest cell development through H3K27me3. Ezh2 conditional null mice were viable
up to birth, but died within the first hour of life. In addition to craniofacial defects, Ezh2 condi-
tional null mice displayed reduced number of ganglion cells in the enteric nervous system.
RT-PCR and ChIP assays indicated aberrant up-regulation of Zic1, Pax3, and Sox10 and
loss of H3K27me3 marks in the promoter regions of these genes in the myenteric plexus.
Overall, these results suggest that Ezh2 is an important epigenetic modifier for the enteric
neural crest cell development through repression of Zic1, Pax3, and Sox10.
Introduction
The neural crest cells (NCCs) are a multipotent cell population which have evolved among
land vertebrates to develop a head, jaw, and sensory nervous system to adapt to predatory life-
styles [1]. The NCCs arise between the neural epithelium and epidermis after neurulation and
migrate throughout the body to generate many different cell types. Depending on their ros-
tro-caudal axis origin and cellular differentiation capabilities, NCCs can be divided into cra-
nial, sacral, cardiac, trunk and vagal NCCs [2]. A number of different genes have been
characterized to be important for the development of NCCs. Bone morphogenetic proteins
(Bmps) and Wnt proteins induce NC formation. Pax3 and Zic1 specify the neural plate border
[3, 4], and Sox10 sustains NCC multipotency [5]. Hox genes, which are critical for body seg-
mentation and axial patterning [6, 7], also affect the development of NCCs [8]. Mutations in
these genes can lead to neurocristopathies, which encompass a wide range of congenital dis-
eases of neural crest cell origin. In some examples of neurocristopathies, such as Hirsh-
sprung’s disease and Waardenburg syndrome, the enteric nervous system (ENS) is
improperly developed, leading to intestinal aganglionosis in the distal portions of the colon
[9]. Most of the ENS develops from vagal NCCs, and some contribution of sacral NCC have
been seen in mice and chicks [10–12]. Although a number of genes have been characterized
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to be associated with the neurocristopathies, the penetrance for the mutant allele of these
genes varies, suggesting a multigenic and potentially epigenetic involvement in manifestation
of these disorders.
The polycomb group genes (PcGs) are epigenetic modifiers that play a significant role in
regulating the expression of Hox genes and many other developmental transcription factors
throughout embryonic development [13, 14]. The two major groups of PcGs include Poly-
comb repression complex 1 (PRC1) and Polycomb repression complex 2 (PRC2). These pro-
tein complexes are evolutionarily well conserved from flying insects to all mammals, including
humans. These two complexes modify histones as an epigenetic signal: the ubiquitination on
lysine 119 of histone 2B (H2BK119) by PRC1 and the methylation on lysine 27 of histone 3
(H3K27) by PRC2. In the case of PRC2, Enhancer of Zeste homolog 2 (Ezh2) is the histone
methyltransferase, adding di- and tri-methyl groups to H3K27. The tri-methylation of H3K27
(H3K27me3) is usually associated with gene repression [15–17]. Complete deletion of Ezh2
leads to early embryonic lethality [18], and tissue specific deletions of Ezh2 display loss of cellu-
lar differentiation [19, 20]. In particular, deletion of Ezh2 in NCCs hinders the development of
craniofacial bone structure in association with the de-repression of Hox genes in the first bra-
chial arch (BA1) cells. In vitro culture of these BA1 cells demonstrated that differentiation fac-
tors such as GFAP and NF160 were properly expressed in Ezh2 conditional null cells [8].
However, these mutant NCCs have not been examined in later stages of embryonic develop-
ment in vivo.
In the current study, we performed a series of conditional knockout experiments targeting
Ezh2 to examine the effect of PRC2 in neural crest cell development in later stages of embryo-
genesis focusing on the ENS development. In addition to aberrant facial structures, conditional
ablation of Ezh2 in NCCs led to improper development of ganglion cells in the ENS and dere-
pression of Pax3, Zic1, and Sox10. Our results suggest a unique epigenetic role of Ezh2 in
enteric neural crest cell development.
Results
Conditional knockout of Ezh2 in neural crest cells leads to perinatal
lethality and abnormal facial structures
To characterize the function of Ezh2 during mouse NCC development, the mutant mice
homozygous for the two loxP sites flanking exon 15 through 18 in 129P2/OlaHsd background
were backcrossed with the Wnt1-Cre line in the 129/B6 mixed background, generating the
Ezh2 homozygous mice in NCC (Ezh2flox/flox;Wnt1-CreT/+; hereafter referred to as ‘Ezh2 null’
mice). Exon deletion and subsequent reduced expression of Ezh2 were further confirmed
through qRT-PCR (S1 Fig). Analysis of early and late embryos from this cross showed the
expected Mendelian ratios, while an increased number of dead Ezh2 null mutants were
observed among the pups found within the first day of birth (Fig 1A, 1B and 1C). The deletion
of Ezh2 in NCC resulted in the lethality around the time of their birth (P0).
Microscopic analyses were performed to examine the facial features of the Ezh2 null pups
(P0). The results are summarized as follows. First, all of the Ezh2 null pups displayed craniofa-
cial defects (n = 30/30), which is consistent with previous observations from the similar mutant
line (Ezh2flox/flox; Wnt1-Cre; Rosa26) at E17.5 stage [8] (Fig 1B and 1C). Mutant features in neo-
natal pups included absence of mandible (Fig 1G, S2, S3 and S6 Figs), absence of tongue (Fig
1G and S6 Fig), abnormal development of the middle ear (Fig 1E), and absence of nasofrontal
plate with herniation of the brain (frontal lobe) and meninges through the extensive cranial
bone defect (meningoencephalocele) (S2 Fig). Second, the Ezh2 null pups displayed absence of
outer ear and microphthalmia (Fig 1D, 1F and 1B, and S2 Fig). Consistent with the fact that
Function of Ezh2 in enteric neural crest cell development
PLOS ONE | https://doi.org/10.1371/journal.pone.0203391 August 31, 2018 2 / 18
the pinna develops from NCCs [21], the pinnae of the outer ear were not visible in any of Ezh2
null mice (n = 30/30) (Fig 1D and 1E, and S6–S8 Figs). Some of the Ezh2 null mice displayed
microphthalmia: the eye was approximately 2/3 the size of that in the wild-type littermates
(n = 5/10) (Fig 1F). Third, a protruding chest (or ‘pigeon’s chest’-like defect) was observed in
some Ezh2 null pups (n = 4/12) (Fig 1B asterisks). The Ezh2 null mice also exhibit defects in
closure and merging of eyelids and upper lip (Fig 1H and 1J). All Ezh2 null mice (n = 30/30)
had incomplete development of eyelids with immature mesenchyme covered by a thin layer of
epithelium remaining in their place (Fig 1D and 1H). We performed toluidine blue staining of
Fig 1. Various facial deformities and perinatal lethality in Ezh2 null mice. A) Ezh2 null mice displays abnormal craniofacial
structures, which are visible at E15.5 and continues through P0 (Ezh2 null, n = 30/30). B) H&E staining shows absence of frontal
face and ‘pigeon’s chest’ (marked in asterisk) (Ezh2 null, n = 4/12). C) Kaplan-Meier survival curve demonstrates perinatal lethality
in Ezh2 null mice within first 40 minutes after birth (n = 35, p = 0.0194, Fisher’s exact test). D) Absence of outer ear in Ezh2 null
mice marked in white box. E) Absence of the outer ear in an H&E-stained transverse section of the head of a Ezh2 null P0 mouse,
and higher magnification of an H&E-stained transverse section of the head revealing aberrant development of the middle ear in the
Ezh2 null P0 mice. Wnt1-Cre-Red arrow: Developing outer ear (pinna and external ear canal), Black arrow: Developing middle ear
(ossicles), Red asterisks: Developing inner ear (left: cochlea; right: cochlea + semicircular canals). Ezh2flox/flox;Wnt1-CreT/+- Red
asterisks: Developing inner ear (cochlea + semicircular canals). There was no evidence of proper middle ear and outer ear
development in any of the transverse sections of the head of the mutant mice. F) The dissected eyes of P0 pups have a 2/3 reduction
in size in Ezh2 null mutants (n = 5/10) compared to the wild-type littermates. G) Circle: Shows primordium of oral cavity. Long
arrow: Points to the space corresponding to the nasal chamber. Short arrow: points to a space that appears to correspond to the
nasopharynx (junction of nasal cavity and pharynx). H) Insufficient closure of the eyelid can be seen in Ezh2 null P0 pups (marked
arrowheads) (n = 30/30). H&E staining shows complete absence of cornea and conjunctiva. I) Toluidine blue staining of P0 pups
showed staining only in the eyelid region of Ezh2 mutants (n = 4/4). J) Cleft lip (or bifid nose) visible in region of the upper lips of
Ezh2 null mice. High magnification of an H&E-stained transverse section of the head of an Ezh2 mutant P0 mice. The arrow in red
points to the nasal pits, and the surrounding cartilage plates are marked with (c) in red. The oral cavity in the center is rudimentary.
https://doi.org/10.1371/journal.pone.0203391.g001
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the mice to characterize the epithelial permeability barrier. As expected, staining was detected
only at the site of the non-developed eyelids of the Ezh2 null mice (Fig 1I). The epithelial bar-
rier was intact throughout the remaining face and body of the Ezh2 null neonatal pups, as the
other areas of the body did not stain. Histologically, the Ezh2 null neonatal pups had no cornea
and conjunctiva, resulting in a malformed anterior segment of the eyes (Fig 1H). Non-NCC
lineage structures, however, such as the retina and the uvea, were similarly developed as those
in the wild-type littermates (Fig 1H). The Ezh2 null mice also displayed incomplete fusion of
the nasal placode (Fig 1J and S9 Fig). Gentle massaging of the stomach in Ezh2 null mutants
after caesarian section released amniotic fluid from the mouth as it did in their wild-type litter-
mates. This suggests that the oral cavity and the gastrointestinal tract are properly connected
in the mutants. All mice, including the Ezh2 null mutants, also had well developed lungs, indi-
cating adequate communication of the lower respiratory tract with the nasopharynx since fetal
breathing of amniotic fluid is required for proper lung development. Overall, conditional dele-
tion of Ezh2 in NCCs resulted in prenatal lethality and severe craniofacial defects.
Reduced number of ganglion cells in the enteric nervous system of Ezh2
null mice
The ganglion cells of the enteric nervous system (ENS) are also of NCC lineage. To examine
proper development of ENS, series of AChE (acetylcholinesterase) histological staining were
performed with the Ezh2 null mutants and the wild-type littermates [22]. The earliest visible
difference in the morphology of these ganglion cells and nerve fibers through AChE staining
was after E18.5, but was the most prominent in neonatal (P0) pups. Complete depletion of
ganglion cells (aganglionosis) was visible in the distal colons of some Ezh2 null mice (n = 3 of 7
Ezh2 null mice) (Fig 2 –bottom panel) while milder reduction of ganglion cells (hypoganglio-
nosis) were apparent in the other Ezh2 null mice (n = 4 of 7 Ezh2 null mice) (Fig 2 –middle
panel). In the proximal colon, approximately 90% and 60% reduction of ganglion cells in com-
parison to its wild type littermate were displayed from the severe and mild cases of hypogan-
glionosis, respectively (p<0.0001) (Fig 2). In addition, the reduction of the enteric nervous
system plexus was also observed in the small intestine and stomach of Ezh2 null mutants com-
pared to those in the wild-type littermates (approximately 50% reduction, p = 0.0011) (S4 and
S17 Figs). In sum, some of the Ezh2 null mice displayed aganglionosis in the distal colon and
the hypoganglionosis was extended to the small intestine and the stomach.
Expression level changes in the whole gut of Ezh2 null mice
The effects of the Ezh2 deletion on the enteric nervous system were further analyzed at the
molecular level in the following manner. First, we examined the expression levels of NCC
developmental genes using the total RNA isolated from the guts of the Ezh2 null embryos and
wild-type littermates at E18.5. Since previous studies observed over-expression of Hox genes in
the BA1 cells of the Ezh2 null mutants, we also tested the expression levels of HoxA9, HoxA1,
HoxA4, HoxA5, HoxB3, and HoxB5 (S5 Fig). According to the results, the majority of the tested
NCC genes were down-regulated in the Ezh2 null embryos compared to their wild-type litter-
mates (Fig 3). The most significant and consistent down-regulation was observed in Phox2b
(n = 4, p = 0.0035) and Sox10 (n = 8, p = 0.0239). In contrast, two genes, Zic1 (n = 6, p = 0.003)
and Pax3 (n = 6, p = 0.019), were 5 to 30 fold up-regulated in the Ezh2 null embryos compared
to their wild-type littermates (Fig 3). A slight up-regulation of HoxA9 and HoxA5 was seen in
some of the Ezh2 null mutants (n = 2), but the levels were not as significant as Pax3 or Zic1 (S5
Fig). Gel electrophoresis of the PCR product from whole gut cDNA confirmed the presence of
Pax3 (226 bp) and Zic1 (235 bp) expression in Ezh2 null mutants and absence of expression in
Function of Ezh2 in enteric neural crest cell development
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its wild-type littermates (S10 Fig). To examine the aberrant spatiotemporal gene expression of
Pax3, series of whole mount RNA in situ hybridization were performed on the E15 gut. All
wild-type embryo guts did not show staining with the anti-Pax3 probe (n = 6), while Ezh2 null
embryo showed staining throughout the entire gut (n = 3) (S10 and S11 Figs).
Expression analysis and epigenetic changes in NCC genes of Ezh2 null mice
in isolated myenteric plexus
To test if the changes in the expression of these NCC developmental genes are in the enteric
nervous system, the myenteric plexus was isolated from P0 neonates in accordance with previ-
ously published protocols by Grundmann et al. [23] (Fig 4A). The expression of Pax3 (n = 3,
p = 0.0010) and Zic1 (n = 3, p = 0.0071) was consistently derepressed in the myenteric plexus
of the Ezh2 null mice, while no expression was observed in the wild-type littermate control. In
contrast to the qRT-PCR data from the whole gut, in which the Sox10 was seen to be down-
regulated in the Ezh2 null mice, a 20-fold up-regulation of Sox10 (n = 4, p = 0.0263) was
detected in the Ezh2 null myenteric plexus cells. Overall, Pax3, Zic1 and Sox10 are aberrantly
expressed in the isolated Ezh2 null myenteric plexus cells (Fig 4B).
Fig 2. Hypoganglionosis in Ezh2 null mice. Whole-mount AChE staining in wild type and Ezh2 null E18.5 mice. AChE stained
proximal and distal colon of wild-type littermate (top panel) and two Ezh2 mutants (bottom panel). The two Ezh2 null mice are
representative of mild (middle panel, Ezh2 null n = 4/7, p<0.0001) hypogangliosis and severe (bottom panel, Ezh2 null n = 3/7,
p<0.0001) aganglionosis cases. The bar graph is the quantification of the AChE staining in the proximal colon. (scale bar = 0.25
mm).
https://doi.org/10.1371/journal.pone.0203391.g002
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Since the H3K27me3 histone modification mark is established through Ezh2 and this modi-
fication is associated with gene repression, ChIP assays with H3K27me3 antibodies (Upstate
07–449, Lot No. DAM1703508) were performed on the isolated myenteric plexus. These
experiments utilized the chromatin isolated from the myenteric plexus of Ezh2 null and wild-
type littermates at E18.5 (Fig 4A). According to the results, Pax3 and Zic1 showed the most sig-
nificantly (p = 0.0011 and p = 0.0035, respectively) reduced levels of H3K27me3 enrichment in
the Ezh2 null embryos (n = 6) compared to those from the wild-type littermates (n = 8) (Fig
4C). In sum, this series of analyses indicated up-regulation of Zic1, Pax3 and Sox10, and
reduced levels of H3K27me3 modifications in the promoter regions of NCC developmental
genes.
Reduced neuronal and glial cells and aberrant accumulation of SOX10 in
Ezh2 null myenteric plexus
To examine the number of neurons and glial cells in the myenteric plexus, the longitudinal
muscle attached to myenteric plexus (LMMPs) was isolated from the ileum and the proximal
colon and were stained with a neuronal marker Hu [24] and a glial marker GFAP. The reduced
number of neuron and glial cells were visible from E16 embryos (Fig 5), and this pattern of
reduced neuronal and glial cells in the Ezh2 null mice continued in P0 neonates (Figs 6 and 7).
On average, approximately 200 neuronal cells were counted per 300μm2 area in wild type P0
Fig 3. NCC developmental gene expression in Ezh2 null mice guts. NCC developmental gene expression levels were compared
between wild-type (grey, Ezh2flox/+Wnt1-CreT/+, Ezh2flox/+Wnt1-Cre+/+, Ezh2+/+ Wnt1-CreT/+, were all combined as wild type
control), and Ezh2 mutant (red) gut tissues with qRT-PCR. The relative gene expression fold difference between Ezh2 null and wild
type littermates are presented. Each bar graph represents a biological replicate. Among the eleven genes tested, four genes displayed
significant expression changes in the Ezh2 null. Phox2b (n = 6, p = 0.0035) and Sox10 (n = 6, p = 0.00239) were down-regulated, and
Zic1 (n = 6, p = 0.003) and Pax3 (n = 6, p = 0.0019) were up-regulated in the Ezh2 null mice.
https://doi.org/10.1371/journal.pone.0203391.g003
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mice while approximately half of that amount of neurons in the same area was seen in the
Ezh2 null myenteric plexus ranging from 39 to 138 neuronal cells (n = 8, p<0.001) (Fig 7).
Immunohistochemistry of GFAP also showed much less amount of GFAP positive cells in the
Ezh2 null mice compared to its littermate control in both E16 and P0 stage myenteric plexuses
(n = 8, p<0.0001) (Figs 5 and 7).
As Sox10 is an early precursor marker for NCCs [25], and it is one of the genes which dis-
played contradicting results in the expression patterns of the whole gut compared to the isolated
myenteric plexus (Figs 3 and 4), the expression patterns of Sox10 in the myenteric plexus of P0
stage neonates were examined with immunohistochemistry. During the enteric nervous system
development, Sox10 is expressed all migrating progenitors of ENCCs, and as the cells differenti-
ate into neuronal lineage, Sox10 is repressed in the neuronal cells and the expression of Sox10
remains only in the glial cells of the developed enteric nervous system [25, 26]. As expected, the
SOX10 immunohistochemistry staining in Ezh2 wild type control mice also did not show much
overlapping expression of SOX10 and Hu (Fig 6 –top panel), and almost complete overlapping
expression of SOX10 and GFAP (Fig 7 –top panel). On the other hand, the Ezh2 null mice dis-
played aberrant overexpression of SOX10 proteins, some of which overlapped with Hu (Fig 6,
bottom panel, white arrow) and some of which overlapped with GFAP (Fig 7 –bottom panel,
white arrow). Other clusters of SOX10 overexpressing cells did not overlap with any of these
markers (Figs 6 and 7). Overall, Ezh2 null mice displayed reduced number of neuronal cells and
glial cells in the myenteric plexus of E16 embryos and P0 stage neonates, and overexpression of
Sox10 proteins were detected in the myenteric plexus P0 stage neonates of Ezh2 null mice.
Discussion
In the current study, we characterized the function of Ezh2 as an epigenetic modifier in
the development of cranial NCCs and ENCCs. First, we described the mutant phenotypes
Fig 4. NCC gene expression analysis and H3K27me3 ChIP assays in myenteric plexus. A) Dissection and isolation of myenteric
plexus from P0 wild-type and Ezh2 null mice for qRT-PCR and ChIP assays. B) qRT-PCR of Pax3, Zic1 and Sox10 in myenteric
plexus. In the Ezh2 null myenteric plexus, Pax3 was upregulated 20–40 fold (n = 3, p = 0.0010), Sox10 was upregulated 5–30 fold
(n = 3, p = 0.0263), and Zic1 was upregulated 40–100 fold (n = 3, p = 0.0071) compared to its wild type littermates. C) H3K27me3
ChIP-qPCR in Ezh2 mutant (in orange) and wild-type littermate (in grey) P0 gut tissues. The amount of precipitated DNA in
promoter regions of NCC developmental genes and HoxA9 are presented as a relative value (%) to that of the input DNA normalized
over a negative locus (beta actin) (y-axis). Student’s t-test (two-tailed) value shows significant difference in H3K27me3 enrichment
between Ezh2 null (n = 6) and wild-type (n = 8) littermates (p<0.01).
https://doi.org/10.1371/journal.pone.0203391.g004
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exhibited by the deletion of Ezh2 in NCCs. Then, we performed qRT-PCR, ChIP assays, and
immunohistochemistry in the neonate myenteric plexus to test potential changes in the
expression and epigenetic modification levels in NCC developmental genes in the Ezh2 null
mice. The results suggest a role for Ezh2 as an epigenetic modifier for the development of
ENCC in regulating the repression of Pax3, Zic1, and Sox10 during the development of the
ENCCs.
The Ezh2 null mice were viable up to birth, but died shortly after (Fig 1). Consistent with
the previous observation, these mice displayed multiple facial deformities, which include the
absence of the jaw bones, underdevelopment of the middle ear, absence of Meckel’s cartilage,
absence of nasofrontal plate with herniation of the brain and meninges (Fig 1) [8, 27]. Some of
the newly described cranial NCC mutant phenotypes include absence of outer ear, incomplete
development of the eyelids, absence of the cornea and conjunctiva, microphthalmia, and bifid
nose (Fig 1). Ezh2 has been conditionally deleted in a large variety of murine cell types to
examine its epigenetic properties during cellular differentiation. For example, conditional
Fig 5. Immunohistochemistry of Hu and GFAP in E16 Ezh2 null mice myenteric plexus. The distribution of Hu expression
(green) and GFAP expression (red) in wild type (top, n = 4) and Ezh2 null (bottom, n = 4) E16 myenteric plexus (scale
bar = 100 μm).
https://doi.org/10.1371/journal.pone.0203391.g005
Function of Ezh2 in enteric neural crest cell development
PLOS ONE | https://doi.org/10.1371/journal.pone.0203391 August 31, 2018 8 / 18
deletion of Ezh2 in skin cells (K14-Cre) led to reduced rate of epidermal differentiation [20],
and deletion of Ezh2 in cortical progenitor cells (Emx1-Cre) led to improper development of
neuronal cells in the brain [28]. Also, Ezh2 deletion in mesenchymal cells (Prrx1-Cre) led to
many different skeletal abnormalities, which included domed head and premature fusion of
the sutures in the skull [29, 30]. The function of Ezh2 in stem cells has been of much interest,
yet its role in NCCs, which exhibit multipotent properties, has not been explored with other
NCC related Cre lines, such as P0-Cre and Sox10-Cre mouse lines [31]. Currently, our studies
and Schwarz et al. are the two publications, reporting the role of Ezh2 in cranial NCC develop-
ment in murine models.
In addition to the cranial NCC defects, aberrant development of ENCCs were also often
seen in Ezh2 null mice (Fig 2). The Ezh2 null mice displayed hypogangliosis in later stages of
embryonic development (E18.5), characterized by hypoganglionosis in the distal colon and
30%-60% reduction in the stomach and small intestine enteric plexus in Ezh2 mutants (Fig 2,
S4 and S17 Figs). Gene expression analysis in the E18.5 whole gut of Ezh2 null mice showed
significant reduction of Sox10 and Phox2b expression and 5 to 30 fold up-regulation of
Pax3 and Zic1 expression compared to its wild-type littermates (Fig 3). The spatial temporal
expression of Pax3 was confirmed through whole mount in situ hybridization of E14.5 gut
(S10 Fig) and the expression of the aberrant transcripts of Pax3, Zic1 and Sox10 were further
confirmed in the isolated myenteric plexus cells (Fig 4). In the myenteric plexus, Sox10, which
was down regulated in the whole gut seemed to also be surprisingly upregulated (Fig 4). The
Fig 6. Double immunofluorescence of Sox10 and Hu in myenteric plexus of P0 neonates. Immunohistochemical analysis of
Sox10 (red) in P0 neonates show non-overlapping expression of Sox10 (red) and Hu (green) in wild-type littermates (top, n = 4),
while Ezh2 null mutants (n = 4) display aberrant overexpression of Sox10 proteins that partially overlap with Hu expression
(bottom) (overlap of Sox10 and Hu marked with white arrow) (p<0.0001, scale bar = 100 μm).
https://doi.org/10.1371/journal.pone.0203391.g006
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Immunohistochemistry of Ezh2 null myenteric plexus from E16 and P0 suggested reduced lev-
els of both neuronal and glial cells and aberrant overexpression of Sox10 in P0 neonates (Figs
5, 6 and 7).
Two possible explanations can be suggested for the outcome of the hypoganglion mutant
phenotype. First, the differentiation capacity of the ENCC precursor cells in Ezh2 null mice
may be lost due to de-repression of Pax3 and Zic1. In Xenopus embryos, the over-expression
of Pax3 and Zic1 was shown to induce the ectopic expression of neural crest differentiation
downstream genes in the ventral region [32, 33]. During ENCC development, the neural plate
border genes may need to be repressed through Ezh2, hence the loss of Ezh2 in these cells
might lead to the aberrant expression of Pax3 and Zic1, resulting in competition for transcrip-
tion factors or changes in chromatin structures of downstream gene enhancers. In the early
NCC induction stage, Pax3 and Zic1 expression may have never been shut down due to the
loss of H3K27me3 repression signals in the Ezh2 mutants. Aberrant expression of Pax3 in the
later stages of NCC development has been reported to manifest cleft palate and abnormal oste-
ogenesis in mice [34]. Zic1 has also been proposed to be repressed in migrating NCCs [35].
However, the derepression of Pax3 and Zic1 in the Ezh2 null mice may be limited to the
ENCCs, since significant upregulation of these genes were not detected in the BA1 cells of
Ezh2 null mice in previous studies [8]. Second, in addition to Pax3 and Zic1, Sox10 was also
significantly up-regulated in the myenteric plexus cells. The conflicting results of Sox10 expres-
sion in the whole gut versus the myenteric plexus may be due to the overall reduced amount of
NC specifier genes in the gut, but increased amount of undifferentiated cells in the myenteric
plexus. Notably, aberrant expression of Sox10 has been linked to hypogangliosis in human
patient studies and in mouse models [36–39]. The immunohistochemical staining of Sox10 in
Ezh2 null mice seem to favor this scenario in that the clusters of Sox10 overexpressing cells
Fig 7. Double immunofluorescence of Sox10 and GFAP in myenteric plexus of P0 neonates. Co-expression analysis of Sox10
(red) and GFAP (green) in wild type (top panel, n = 4) and Ezh2 null (bottom panel, n = 4) myenteric plexus (p<0.001, scale
bar = 100 μm).
https://doi.org/10.1371/journal.pone.0203391.g007
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overlap with neither neuronal nor glial cells (Figs 6 and 7) and seem to have adopted its own
unique cell fate.
It is also possible that Hox genes are epigenetically altered in the ENS of the Ezh2 mutants,
since Hox genes has been linked to megacolon phenotypes [40], and combined mutations in
Ret and Hox genes have been previously linked to increased penetrance of Hirschsprung’s dis-
ease [41]. However, in the current studies, we have seen up-regulation of Pax3 and Zic1, but
not HoxA9, which was one of the most significantly up-regulated genes in the BA1 cells of
Ezh2 null mutants [8]. It is interesting that the upregulated genes between the cranial NCCs
are not shared in the ENCCs. The transcriptional levels of other Hox genes, HoxA1, HoxA4,
HoxA5, HoxB3, and HoxB5, which are involved in the enteric nervous system development
[40, 42–45], were also tested. However, their gene expression levels were not significantly
altered in the Ezh2 null mice (S5 Fig). Although ChIP assays suggest reduced H3K27me3 mark
in HoxA9 promoter region, it is puzzling to see no changes in gene expression. A number of
factors have been suggested to play a role in affecting the transcriptional machinery of PRC2,
including how the PRC2 subunits such as Suz12, Eed, and Ezh1 are assembled, and how these
complexes interacts with other cofactors such as Jarid2 and Aebp2 [46]. The removal of
H3K27me3 alone have been demonstrated be insufficient to activate its downstream genes
[47]. Future studies in comparing the Ezh2 null cranial NCCs to its ENCCs and identifying the
types of transcription factors that may respond to the loss of H3K27me3 and recruit gene
expression machinery to its downstream genes may help to characterize the mechanism in
how Ezh2 affects NCC development. Also, systematic characterization of H3K27me1,
H3K27me2, and H3K27me3 during ENCC development may help us to understand some dis-
crepancies between the ChIP results and the expression data. The limitations of the
H3K27me3 antibody [48] must also be considered, since it may not be able to distinguish
H3K27me1, H3K27me2 and H3K27me3, in which their downstream gene expression out-
comes can vary significantly [49].
Hirschsprung’s disease (HSCR) occurs 1 in every 5000 live birth. In the majority of the
cases, the HSCR are isolated with no other congenital anomalies, while 10% of the cases are
presented with other complications such as craniofacial or heart defects [50, 51]. Our mouse
model presents aberrant development of the enteric neural crest cells which resembles the
Hirschsprung’s disease phenotype. However, due to other complications, they are perinatally
lethal (Fig 1). The Wnt1-Cre line have been a historically standard mouse line to study NCC
development, and a number of epigenetic modifiers such as Dnmt [52] and Dicer [53] have
also been conditionally deleted with the Wnt1-Cre mice (S1 Table). While the Wnt1-Cre line
has provided much elucidation in understanding the biology of NCC development, this classi-
cal Wnt1-Cre mice have been shown to ectopically express Wnt1 during early stages of devel-
opment [54]. This may explain the variable penetrance we were seeing in the gut of Ezh2 null
mice (Fig 2). A recent new mouse line Wnt1-Cre2 have been presented as an improved mouse
system to examine NCC development [54]. Careful investigation of the gastrointestinal tract
with Ezh2 deletion of this mouse model would be desired in the near future. Nevertheless, this
study is the first to suggest a potential epigenetic role of Ezh2 in enteric neural crest cell
development.
NCCs played a significant role in vertebrate evolution, including adaptation to the environ-
ment through formation of the head, and advancement in sensory function as well as complex
signaling between the gut and the brain [1, 55]. Further understanding the conserved tran-
scriptional regulatory mechanisms involved in the differentiation of cranial NCCs compared
to vagal and sacral NCCs may help us to understand the process by which these mutipotent
cell lineages have evolved. Moreover, characterizing the epigenetic modifications involved in
regulating the spatiotemporal expression of these transcription factors can add to another
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layer of deciphering the gene regulatory network responsible for NCC development. In this
study, we show the importance of Ezh2’s role as an epigenetic modifier in cranial and non-cra-
nial NCC development, and we propose the involvement of the H3K27me3 epigenetic mecha-
nism in repressing some of the neural crest cell developmental genes which can manifest a
Hirschsprung’s disease-like phenotype. The NCCs are a great cell system to decipher the func-
tion of epigenetic modifiers, since it can give rise to many different cell types in the body of
vertebrates. We hope that these studies would shed light in the understanding of the functions
of histone modifiers and their roles in manifesting various neurocristopathies.
Material and methods
Ethics statement
All the experiments related to mice were performed in accordance with the National Institutes
of Health guidelines for care and use of animals, and also approved by the Louisiana State Uni-
versity Institutional Animal Care and Use Committee (IACUC), protocol #16–009.
Animals
The Ezh2 conditional knockout mice were derived as previously described [56]. Presence of a
loxP site insertion was confirmed through polymerase chain reaction (PCR) amplification
with the following primers: LoxF- CCCATTGAGAGTGCTGACTCA; LoxR- ACCTCGCTATGT
GTAACCAGT, and F3.1- TCTTAGCACTTGCTTGTTCCCATTG. Expected fragment sizes were
100 bp without the loxP insertion and 120 bp with the loxP insertion (S1 Fig). Template DNA
was acquired through mouse ear clips that had been digested in tail lysis buffer (0.1 M Tris-Cl,
5 mM EDTA, 0.2% SDS, 0.2 M NaCl, pH 8.0, 20 μg/ml Proteinase K). E15.5 and E18.5
embryos were harvested through timed mating between Ezh2flox/flox; Wnt1-CreT/+ double
mutant backcrossed with Ezh2flox/flox. The survival curve was generated by combining four lit-
ters of cesarean sections (n = 40). Pups delivered through cesarean sections were massaged on
the abdomen, and fluid was gently removed from the nasal and oral cavity using Kimwipes.
The p value was derived using the Fisher exact statistical test. All mouse work was approved by
the IACUC committee at Louisiana State University.
Histology
Embryos and neonatal mice were fixed for 24–28 hours in 10% formalin and subsequently
moved into 70% ethanol for storage. Tissue were trimmed and routinely embedded in paraffin,
sectioned, and stained with hematoxylin and eosin (H&E).
Toluidine blue staining
Toluidine blue staining was performed as previously described [57]. In brief, unfixed neonates
were incubated in 100% methanol for 5 minutes and then stained in 0.1% toluidine blue dye
for 20 minutes.
AChE staining
Acetylcholinesterase (AChE) staining was performed according to a previously described pro-
tocol [22]. In brief, the dissected stomach and intestines were fixed in 4% paraformaldehyde
for 2 hours at 4˚C and moved to saturated sodium sulfate solution overnight at 4˚C. Then, the
tissues were incubated in the staining buffer (0.2 mM ethopropazine HCl, 4 mM acetylthio-
choline iodide, 10 mM glycine, 2 mM cupric sulfate, and 65 mM sodium acetate pH 5.5) for
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4–5 hours at room temperature. Lastly, acetylcholinesterase staining was completed by incu-
bating the stomach and intestines in 1.25% sodium sulfide pH 6 for 1.5 minutes.
RT-PCR
The whole gut and the myenteric plexus (according to Grundmann et al. [23]) was isolated and
snap frozen in liquid nitrogen. After adding Trizol (Invitrogen) into frozen tissues, the tissues
were further minced into smaller fragments with sterile scissors in Trizol. Tissue fractions in Tri-
zol were left on ice for 30 minutes and total RNA was isolated as described by manufacture’s pro-
tocol (Invitrogen). Isolated RNA was resuspended in nuclease-free water and cDNA was
synthesized with MMLV reverse transcriptase (Invitrogen) according to manufacture’s protocol.
Chromatin immunoprecipitation assay
The P0 neonatal intestine was dissected and the myenteric plexus was isolated with Liberase
TH (Roche) [23]. Tissues were homogenized in cold 1X PBS and fixed in 0.1% PFA v/v at
37˚C for 20 minutes. After three consecutive washes with cold 1X PBS, the crosslinked tissues
were placed in the lysis buffer (1% SDS, 10mM EDTA, 50mM Tris-Cl pH8.1) for sonication.
Chromatin fraction was pre-cleared with protein A/G agarose beads (Cat. No. sc-2003, Santa
Cruz) and pre-immune serum for 2 hours. After spinning down agarose beads, the remaining
supernatant was used for immunoprecipitation with H3K27me3 antibody (Cat. No. 07–449,
Upstate Biotech. Lot No. DAM1703508). The myenteric plexus isolated from two P0 neonates
were combined per ChIP assay, and each ChIP assay was repeated at least three times (n = 8
wild-type, n = 6 Ezh2 null).
Whole mount RNA in situ hybridization
The E15 embryo guts were dissected and fixed in 4% PFA overnight in 4˚C. The whole mount
RNA in situ hybridization was performed as described previously [58] with anti-Pax3 probe
hybridization at 68˚C. The images were captured with Olympus DP70 camera attached to the
Olympus SZX7 stereo microscope.
Immunohistochemical procedures
The longitudinal muscle attached to the myenteric plexus (LMMP) was isolated from embry-
onic day 16 (E16) and P0 guts and fixed for 30 minutes in room temperature in 4% parafor-
maldehyde. After twenty-minute treatment in 0.05% Triton-X in 1X PBS, the LMMPs were
blocked for endogenous peroxidase activity by incubation in 3% hydrogen peroxide for one
hour in room temperature. The LMMPs were pre-blocked in blocking solution (1% BSA, 0.3%
Triton-X in 1X PBS) for 2 hours at room temperature, and incubated in blocking solution
with primary antibodies with gentle rocking at room temperature overnight. The dilutions for
the primary antibody are as follows: Sox10 antibody (Santa Cruz, cat. sc365692, 1:100), GFAP
antibody (Santa Cruz, cat. 33673, 1:50), HuD antibody (Santa Cruz, cat. sc28299, 1:1000). The
bound antibodies were detected with Alexa Flour 488 (Invitrogen, cat. A11001, 1:200) and
Alexa Flour tyramide (Invitrogen, cat. B40942) according to its manufacture’s protocols. The
cells were imaged on Leica DM2500 microscope and the images were captured with 18.2 Color
Mosaic camera from Diagnostic Instruments, Incorporated.
Data analysis
The current data presented were obtained from at least three biological replicates from three
different mice litters and at least two experimental replicates. The survival was assessed
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through the Kaplan-Meier curve, and the associated p value was derived from the Fisher exact
test. The p values evaluating the penetrance of the mutant phenotypes were also derived
through the Fisher exact test. The statistical significance of the real-time qRT-PCR values for
expression analysis and ChIP assays was evaluated using the two-tailed Student’s t-test. Proper
amplification of PCR products were validated through gel electrophoresis following qPCR
reactions (S15 and S16 Figs). All the primer sequences are presented in the supporting infor-
mation (S13 and S14 Figs). The neuronal cells were quantified by counting the number of neu-
rons in 300μm2 area of at least eight images obtained from four mice of each wild type and
mutant genotypes (n = 4 wild type, n = 4 Ezh2 null). The glial cells were counted in GFAP pos-
itive cluster in 300μm2 area of at least eight images from four mice of each wild type and
mutant genotypes. The statistical significance was tested through two-tailed Student’s t-test.
The density of the nerve fibers from the AChE staining were imaged in a set magnification and
was quantified through skeletal reconstruction of the ganglion cells on image J and the number
of intersections were counted and divided by the relative distance analyzed (S12 Fig).
Supporting information
S1 Fig. Quantification of Ezh2 transcripts and genotyping of Ezh2 null pup. This file con-
tains qRT-PCR results of Ezh2 transcripts and agarose gel electrophoresis images of the Ezh2
genotyping.
(JPG)
S2 Fig. Morphological evaluation of Ezh2 null pups using micro CT. This file contains a set
of images showing 2D and 3D microCT images of wild type and Ezh2 null pups.
(JPG)
S3 Fig. Morphological evaluation of Ezh2 null E15.5 embryos using micro CT. This file con-
tains a set of images of wild type and Ezh2 null E15.5 embryos using micro CT.
(JPG)
S4 Fig. Comparison of the AChE staining patterns in the P0 Ezh2 null pups to its wild type
littermates in the small intestine. This file contains images of AChE stained small intestine in
wild type and Ezh2 null pups.
(JPG)
S5 Fig. Expression analysis of Hox genes in the Ezh2 null and wild type guts. This file con-
tains qRT-PCR results of Hox genes in the gastrointestinal tracts of Ezh2 null mice.
(JPG)
S6 Fig. Zoomed in view of Fig 1G. This file contains a zoomed in view of H&E staining pre-
sented in Fig 1G.
(JPG)
S7 Fig. Zoomed in view of Fig 1E Ezh2 wild type. This file contains a zoomed in view of H&E
staining presented in Fig 1E.
(JPG)
S8 Fig. Zoomed in view of Fig 1E Ezh2 null. This file contains a zoomed in view of H&E
staining presented in Fig 1E.
(JPG)
S9 Fig. Zoomed in view of Fig 1J Ezh2 null. This file contains a zoomed in view of H&E stain-
ing presented in Fig 1J.
(JPG)
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S10 Fig. Ectopic expression of Pax3 and Zic1 transcripts in the Ezh2 null pups. This file
contains agarose gel images of Pax3 and Zic1 RT-PCR products from Ezh2 null guts, and
whole mount in situ hybridization of Pax3 in wild type and Ezh2 null guts of E15 embryos.
(JPG)
S11 Fig. In situ hybridization of Pax3 sense probe. This file contains an image of in situ
hybridization with Pax3 sense probe.
(JPG)
S12 Fig. Quantification method used to analyze the AChE stained images. This file contains
an image of an overview for quantifying the AChE stained images.
(JPG)
S13 Fig. Primer sequences for NCC cDNA qRT-PCR. This file contains the primer sequences
for NCC qRT-PCR.
(DOCX)
S14 Fig. Primer sequences for NCC ChIP assays. This file contains the primer sequences for
NCC ChIP assays.
(DOCX)
S15 Fig. Validation of NCC cDNA qRT-PCR primers. This file contains agarose gel electro-
phoresis image of all NCC cDNA primers used in this study.
(JPG)
S16 Fig. Validation of NCC ChIP assay primers. This file contains agarose gel electrophore-
sis images of all NCC ChIP assay primers used in this study.
(JPG)
S17 Fig. AChE staining of Ezh2 null stomachs. This file contains an image of wild type and
Ezh2 null P0 stomachs.
(JPG)
S1 Table. Table summarizing the results of epigenetic modifiers conditionally deleted with
Wnt-Cre. This file contains a table summarizing the results of epigenetic modifiers that were
deleted with Wnt1-Cre. The phenotypes reported in this current study are marked in red.
(JPG)
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